e-learning
resources
London 2016
Tuesday, 06.09.2016
Exploring mechanisms in health and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting
V Pratibh Prasad (Secunderabad, India), V. Pratibh Prasad, Jai Mullerpattan, Radhika Banka, Avinash Gandhare, Lancelot Pinto
Source:
International Congress 2016 – Exploring mechanisms in health and disease
Session:
Exploring mechanisms in health and disease
Session type:
Poster Discussion
Number:
3434
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V Pratibh Prasad (Secunderabad, India), V. Pratibh Prasad, Jai Mullerpattan, Radhika Banka, Avinash Gandhare, Lancelot Pinto. Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting. Eur Respir J 2016; 48: Suppl. 60, 3434
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Study assoicção between severity stages of chronic obstructive pulmonary disease and fasting glucose in patients with this disease
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013
Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Prognostic significance of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
COPD
Source: Respipedia Article
Year: 2018
Red blood cell distribution with in patients With chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Use of clinical characteristics to predict spirometric classification of obstructive lung disease
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept